Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT)

2.01
Delayed Data
As of May 25
 -0.06 / -2.90%
Today’s Change
0.93
Today|||52-Week Range
2.88
+86.11%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Eyepoint Pharmaceuticals Inc have a median target of 4.50, with a high estimate of 6.00 and a low estimate of 2.50. The median estimate represents a +123.88% increase from the last price of 2.01.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Eyepoint Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.11
Sales
$792.3K
Reporting Date
Sep 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 25.00%
 
 
 
 
 
 
Growthannually 5.13%
 
 
 
 
 
 

Sales

Growthquarterly -14.63%
 
 
 
 
 
 
Growthannually -61.06%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.